RUNWEST 2021 – Update

NAB RunWest is Western Sydney’s premier community event and the first ever major running festival, it was held on Sunday March … Sunday, March 28, 2021. A team was organised by Dan as his girlfriend has recently started treatment for Lupus and has battled with several of its symptoms for the past 7 years. Following…

AstraZeneca Lupus Preceptorship

The AZ “lupus” medical team have organised to host an internal preceptorship with Prof Eric Morand Monash University and guest speaker Barbara Ward President Lupus Australia. The meeting was undertaken on the 19th March 2021. This is a new therapy area for AZ, and Barbara will be giving some insight into patient advocacy for lupus…

BBQ Bunnings Gladesville

On Saturday 13th March Bunnings Gladesville, supported a group of Lupus Volunteers to undertake a Sausage Sizzle to help raise awareness of Lupus. The day was a roaring success with over 800 sausages sold on the day along with a large quantity of drinks. It was extraordinary the number of people that had some understanding…

Alpha Project 2

Global Advisory Committee Identifies Solutions for Addressing Top Lupus Barriers The Addressing Lupus Pillars for Health Advancement (ALPHA) project is a unique global consensus initiative that seeks to identify and prioritize the fundamental barriers or knowledge gaps that will allow providers, researchers and scientists to improve diagnosis, treatment and systems of care for people with…

US FDA approves Lupkynis (voclosporin)

More great news for people with lupus! The U.S. Food and Drug Administration (FDA) has approved Lupkynis™ (voclosporin) to treat lupus nephritis (lupus-related kidney disease) in adults when used in combination with a background immunosuppressive therapy regimen. Lupkynis is the second new therapy authorized to treat this potentially life-threatening complication of lupus. Developed by Aurinia…

US FDA approve Benlysta

GSK’s Benlysta® (belimumab) is First Lupus Nephritis Treatment Approved by FDA The U.S. Food and Drug Administration (FDA) in late December 2020 approved Benlysta® to treat lupus nephritis (lupus-related kidney disease) in adults. The decision makes Benlysta the first lupus therapy authorized to treat this potentially life-threatening complication of the disease. Another milestone, this new…